

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-mediated cell contraction (GO:0070252) | 9.70919920 |
| 2 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 9.63138780 |
| 3 | skeletal muscle adaptation (GO:0043501) | 9.19118659 |
| 4 | skeletal muscle fiber development (GO:0048741) | 7.63756946 |
| 5 | plasma membrane repair (GO:0001778) | 7.25690111 |
| 6 | actin filament-based movement (GO:0030048) | 7.12668117 |
| 7 | skeletal muscle tissue regeneration (GO:0043403) | 6.71266704 |
| 8 | purine nucleotide salvage (GO:0032261) | 6.57838455 |
| 9 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.48024011 |
| 10 | myotube cell development (GO:0014904) | 6.38358442 |
| 11 | striated muscle contraction (GO:0006941) | 6.23555831 |
| 12 | glycogen catabolic process (GO:0005980) | 6.16580739 |
| 13 | IMP metabolic process (GO:0046040) | 6.10873805 |
| 14 | sarcomere organization (GO:0045214) | 6.06761460 |
| 15 | creatine metabolic process (GO:0006600) | 6.02728792 |
| 16 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.90455097 |
| 17 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.78982578 |
| 18 | glucan catabolic process (GO:0009251) | 5.75225684 |
| 19 | cytidine deamination (GO:0009972) | 5.50967295 |
| 20 | cytidine metabolic process (GO:0046087) | 5.50967295 |
| 21 | cytidine catabolic process (GO:0006216) | 5.50967295 |
| 22 | myofibril assembly (GO:0030239) | 5.36651521 |
| 23 | IMP biosynthetic process (GO:0006188) | 5.34418504 |
| 24 | cellular polysaccharide catabolic process (GO:0044247) | 5.34221847 |
| 25 | striated muscle atrophy (GO:0014891) | 5.33111755 |
| 26 | response to muscle activity (GO:0014850) | 5.31706270 |
| 27 | carnitine shuttle (GO:0006853) | 5.29104367 |
| 28 | muscle contraction (GO:0006936) | 5.17929063 |
| 29 | polysaccharide catabolic process (GO:0000272) | 5.13728895 |
| 30 | striated muscle adaptation (GO:0014888) | 4.98194310 |
| 31 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.97254996 |
| 32 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.90122055 |
| 33 | response to inactivity (GO:0014854) | 4.77960619 |
| 34 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.70893924 |
| 35 | behavioral response to nicotine (GO:0035095) | 4.69281596 |
| 36 | glycogen biosynthetic process (GO:0005978) | 4.62617743 |
| 37 | glucan biosynthetic process (GO:0009250) | 4.62617743 |
| 38 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.61762890 |
| 39 | muscle system process (GO:0003012) | 4.56573259 |
| 40 | muscle fiber development (GO:0048747) | 4.53488347 |
| 41 | muscle atrophy (GO:0014889) | 4.43833855 |
| 42 | regulation of cell communication by electrical coupling (GO:0010649) | 4.38450961 |
| 43 | fatty acid transmembrane transport (GO:1902001) | 4.27418725 |
| 44 | 2-oxoglutarate metabolic process (GO:0006103) | 4.23248537 |
| 45 | actomyosin structure organization (GO:0031032) | 4.18325641 |
| 46 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.15873080 |
| 47 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.15469540 |
| 48 | neuronal action potential propagation (GO:0019227) | 4.12432997 |
| 49 | carnitine transmembrane transport (GO:1902603) | 4.06751404 |
| 50 | glycogen metabolic process (GO:0005977) | 4.00650375 |
| 51 | muscle cell cellular homeostasis (GO:0046716) | 3.94721376 |
| 52 | glucan metabolic process (GO:0044042) | 3.91952061 |
| 53 | cellular glucan metabolic process (GO:0006073) | 3.91952061 |
| 54 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.87590492 |
| 55 | muscle adaptation (GO:0043500) | 3.85736159 |
| 56 | negative regulation of muscle hypertrophy (GO:0014741) | 3.83794011 |
| 57 | regulation of coenzyme metabolic process (GO:0051196) | 3.80777230 |
| 58 | regulation of cofactor metabolic process (GO:0051193) | 3.80777230 |
| 59 | DNA double-strand break processing (GO:0000729) | 3.70712652 |
| 60 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.69234894 |
| 61 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.67940716 |
| 62 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.66744034 |
| 63 | striated muscle cell development (GO:0055002) | 3.66379256 |
| 64 | carnitine transport (GO:0015879) | 3.64665958 |
| 65 | amino-acid betaine transport (GO:0015838) | 3.64665958 |
| 66 | response to activity (GO:0014823) | 3.64636039 |
| 67 | tricarboxylic acid cycle (GO:0006099) | 3.60737158 |
| 68 | mannosylation (GO:0097502) | 3.58646522 |
| 69 | ubiquinone biosynthetic process (GO:0006744) | 3.57896671 |
| 70 | muscle organ development (GO:0007517) | 3.56639434 |
| 71 | cardiac muscle contraction (GO:0060048) | 3.53753852 |
| 72 | regulation of sequestering of triglyceride (GO:0010889) | 3.52591847 |
| 73 | muscle structure development (GO:0061061) | 3.51281920 |
| 74 | cellular carbohydrate catabolic process (GO:0044275) | 3.48376547 |
| 75 | nucleotide salvage (GO:0043173) | 3.42105714 |
| 76 | cellular response to dexamethasone stimulus (GO:0071549) | 3.41961610 |
| 77 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.39541416 |
| 78 | synaptic transmission, cholinergic (GO:0007271) | 3.37842722 |
| 79 | glyoxylate metabolic process (GO:0046487) | 3.36907807 |
| 80 | protein hydroxylation (GO:0018126) | 3.33768697 |
| 81 | cardiac muscle cell development (GO:0055013) | 3.31929548 |
| 82 | neuromuscular synaptic transmission (GO:0007274) | 3.30842960 |
| 83 | regulation of memory T cell differentiation (GO:0043380) | 3.29705265 |
| 84 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.28155773 |
| 85 | interkinetic nuclear migration (GO:0022027) | 3.26426493 |
| 86 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.25542646 |
| 87 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.24999569 |
| 88 | NADH metabolic process (GO:0006734) | 3.23242382 |
| 89 | skeletal muscle tissue development (GO:0007519) | 3.15751254 |
| 90 | response to dexamethasone (GO:0071548) | 3.14552896 |
| 91 | histone H3 deacetylation (GO:0070932) | 3.12595966 |
| 92 | histone H4 deacetylation (GO:0070933) | 3.11519022 |
| 93 | myotube differentiation (GO:0014902) | 3.11470932 |
| 94 | muscle cell development (GO:0055001) | 3.09928357 |
| 95 | ubiquinone metabolic process (GO:0006743) | 3.09529772 |
| 96 | muscle cell fate commitment (GO:0042693) | 3.08153732 |
| 97 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.07168744 |
| 98 | positive regulation of myotube differentiation (GO:0010831) | 3.06431679 |
| 99 | cardiac cell development (GO:0055006) | 3.02774148 |
| 100 | regulation of sulfur metabolic process (GO:0042762) | 2.99310426 |
| 101 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.96129571 |
| 102 | regulation of relaxation of muscle (GO:1901077) | 2.96035564 |
| 103 | heart contraction (GO:0060047) | 2.93418921 |
| 104 | heart process (GO:0003015) | 2.93418921 |
| 105 | succinate metabolic process (GO:0006105) | 2.90981364 |
| 106 | DNA deamination (GO:0045006) | 2.88821914 |
| 107 | AMP metabolic process (GO:0046033) | 2.87964020 |
| 108 | cardiac myofibril assembly (GO:0055003) | 2.87825513 |
| 109 | regulation of glucokinase activity (GO:0033131) | 2.87498750 |
| 110 | regulation of hexokinase activity (GO:1903299) | 2.87498750 |
| 111 | myoblast fusion (GO:0007520) | 2.87220855 |
| 112 | amino acid salvage (GO:0043102) | 2.86520875 |
| 113 | L-methionine salvage (GO:0071267) | 2.86520875 |
| 114 | L-methionine biosynthetic process (GO:0071265) | 2.86520875 |
| 115 | arginine catabolic process (GO:0006527) | 2.84820212 |
| 116 | cellular polysaccharide metabolic process (GO:0044264) | 2.83586146 |
| 117 | purine-containing compound salvage (GO:0043101) | 2.83047465 |
| 118 | cellular polysaccharide biosynthetic process (GO:0033692) | 2.82701094 |
| 119 | polysaccharide biosynthetic process (GO:0000271) | 2.82322385 |
| 120 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.81020066 |
| 121 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.79263337 |
| 122 | regulation of striated muscle contraction (GO:0006942) | 2.78761628 |
| 123 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.77456582 |
| 124 | positive regulation by host of viral transcription (GO:0043923) | 2.76716689 |
| 125 | macroautophagy (GO:0016236) | 2.75516978 |
| 126 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.73793836 |
| 127 | positive regulation of protein kinase C signaling (GO:0090037) | 2.73715914 |
| 128 | quinone biosynthetic process (GO:1901663) | 2.73548061 |
| 129 | positive regulation of cation channel activity (GO:2001259) | 2.72136111 |
| 130 | protein ADP-ribosylation (GO:0006471) | 2.71424021 |
| 131 | regulation of actin filament-based movement (GO:1903115) | 2.69494243 |
| 132 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.69077382 |
| 133 | negative regulation of cell killing (GO:0031342) | 2.69077382 |
| 134 | protein-cofactor linkage (GO:0018065) | 2.68802640 |
| 135 | muscle organ morphogenesis (GO:0048644) | 2.66011639 |
| 136 | valine metabolic process (GO:0006573) | 2.64856133 |
| 137 | Peyers patch development (GO:0048541) | 2.63985590 |
| 138 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.63985590 |
| 139 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.62192574 |
| 140 | DNA methylation involved in gamete generation (GO:0043046) | 2.61689874 |
| 141 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.60714720 |
| 142 | negative regulation of potassium ion transport (GO:0043267) | 2.59838024 |
| 143 | mitochondrial genome maintenance (GO:0000002) | 2.57743292 |
| 144 | positive regulation of defense response to virus by host (GO:0002230) | 2.55457496 |
| 145 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.52451018 |
| 146 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.48650685 |
| 147 | adult heart development (GO:0007512) | 2.47678757 |
| 148 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.45190930 |
| 149 | actin-myosin filament sliding (GO:0033275) | 11.9896885 |
| 150 | muscle filament sliding (GO:0030049) | 11.9896885 |
| 151 | regulation of skeletal muscle contraction (GO:0014819) | 11.4883361 |
| 152 | skeletal muscle contraction (GO:0003009) | 10.7209122 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.86606533 |
| 2 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.60492767 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.44970442 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.40818325 |
| 5 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 3.18004341 |
| 6 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.17706609 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.17423168 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.01884236 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.80623572 |
| 10 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.53545598 |
| 11 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.50308230 |
| 12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.48475160 |
| 13 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.37981499 |
| 14 | * BCL6_27268052_Chip-Seq_Bcells_Human | 2.25364698 |
| 15 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.14817310 |
| 16 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 2.02790874 |
| 17 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.00542063 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.95674007 |
| 19 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.92455023 |
| 20 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 1.91063140 |
| 21 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.90311467 |
| 22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.89949514 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89704655 |
| 24 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.87548232 |
| 25 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 1.86505987 |
| 26 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.86274964 |
| 27 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.81032422 |
| 28 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.81032422 |
| 29 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.81032422 |
| 30 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.80199561 |
| 31 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.77477251 |
| 32 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.77025909 |
| 33 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.76858265 |
| 34 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.76699221 |
| 35 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.74497278 |
| 36 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.72166261 |
| 37 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.63992772 |
| 38 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.62496959 |
| 39 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.62434699 |
| 40 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.59474715 |
| 41 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.58258855 |
| 42 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.56786794 |
| 43 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.56786794 |
| 44 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.55574802 |
| 45 | SA1_27219007_Chip-Seq_Bcells_Human | 1.55006200 |
| 46 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.54874594 |
| 47 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.54790865 |
| 48 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.54486200 |
| 49 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.50462882 |
| 50 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.49663839 |
| 51 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.49209630 |
| 52 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.47832170 |
| 53 | ATF3_27146783_Chip-Seq_COLON_Human | 1.47665382 |
| 54 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.47024357 |
| 55 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.46769022 |
| 56 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.45398637 |
| 57 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.45202138 |
| 58 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.44386454 |
| 59 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.43486690 |
| 60 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.43273699 |
| 61 | ERA_21632823_ChIP-Seq_H3396_Human | 1.43014155 |
| 62 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.42724849 |
| 63 | UTX_26944678_Chip-Seq_JUKART_Human | 1.41198548 |
| 64 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.40738664 |
| 65 | MAF_26560356_Chip-Seq_TH1_Human | 1.39786953 |
| 66 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.39033695 |
| 67 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.37719266 |
| 68 | * P300_27268052_Chip-Seq_Bcells_Human | 1.37661241 |
| 69 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34837100 |
| 70 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.34489248 |
| 71 | P68_20966046_ChIP-Seq_HELA_Human | 1.31760819 |
| 72 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.31690949 |
| 73 | VDR_22108803_ChIP-Seq_LS180_Human | 1.31667467 |
| 74 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.30989847 |
| 75 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30668721 |
| 76 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.30449573 |
| 77 | * MAF_26560356_Chip-Seq_TH2_Human | 1.30253334 |
| 78 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.28953561 |
| 79 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27538764 |
| 80 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.26907678 |
| 81 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.26494383 |
| 82 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.26017038 |
| 83 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.25587497 |
| 84 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.24158555 |
| 85 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.23939514 |
| 86 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.23335385 |
| 87 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22570630 |
| 88 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.22415925 |
| 89 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.21801700 |
| 90 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.20130983 |
| 91 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.20033291 |
| 92 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.19492969 |
| 93 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.18764190 |
| 94 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.18300453 |
| 95 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.18133680 |
| 96 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.17216806 |
| 97 | * MYC_19829295_ChIP-Seq_ESCs_Human | 1.16994126 |
| 98 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.16975475 |
| 99 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.15941446 |
| 100 | * RAC3_21632823_ChIP-Seq_H3396_Human | 1.15403291 |
| 101 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.15229900 |
| 102 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13998675 |
| 103 | * FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.13521050 |
| 104 | * P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 1.13004539 |
| 105 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.12647738 |
| 106 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.12178084 |
| 107 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11859221 |
| 108 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.11797326 |
| 109 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.11411872 |
| 110 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.11374284 |
| 111 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.11363642 |
| 112 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.11323895 |
| 113 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.10873361 |
| 114 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.10205722 |
| 115 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.09693616 |
| 116 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.09418919 |
| 117 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.08341779 |
| 118 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.08253608 |
| 119 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.08096523 |
| 120 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.07453639 |
| 121 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.06779955 |
| 122 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.06403436 |
| 123 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.05555317 |
| 124 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.05356191 |
| 125 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.05282799 |
| 126 | MYC_22102868_ChIP-Seq_BL_Human | 1.04656310 |
| 127 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.04616987 |
| 128 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.04523970 |
| 129 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04236469 |
| 130 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.03740125 |
| 131 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.02773111 |
| 132 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02731051 |
| 133 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.02527002 |
| 134 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02129952 |
| 135 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01740019 |
| 136 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01465417 |
| 137 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.01155968 |
| 138 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99060062 |
| 139 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.97910066 |
| 140 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97569460 |
| 141 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97386623 |
| 142 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.97166485 |
| 143 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.96998008 |
| 144 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.96966350 |
| 145 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.96876122 |
| 146 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.96696285 |
| 147 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.95099509 |
| 148 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.94671377 |
| 149 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.94399074 |
| 150 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.93422301 |
| 151 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.93276013 |
| 152 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.92785871 |
| 153 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92118354 |
| 154 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.91532404 |
| 155 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.91109038 |
| 156 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.90793894 |
| 157 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.90528667 |
| 158 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90240688 |
| 159 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.90184120 |
| 160 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.90111919 |
| 161 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.89310062 |
| 162 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.89255666 |
| 163 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.88432082 |
| 164 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.88249502 |
| 165 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87985430 |
| 166 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.87971248 |
| 167 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.87731835 |
| 168 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.87542411 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 7.91478367 |
| 2 | MP0003646_muscle_fatigue | 6.40081848 |
| 3 | MP0000749_muscle_degeneration | 6.23841716 |
| 4 | MP0000751_myopathy | 5.35153441 |
| 5 | MP0000747_muscle_weakness | 4.54020602 |
| 6 | MP0002106_abnormal_muscle_physiology | 4.19379596 |
| 7 | MP0002269_muscular_atrophy | 3.86710722 |
| 8 | MP0004036_abnormal_muscle_relaxation | 3.86433151 |
| 9 | MP0000759_abnormal_skeletal_muscle | 3.79547220 |
| 10 | MP0000750_abnormal_muscle_regeneration | 3.53591880 |
| 11 | MP0005369_muscle_phenotype | 3.47219841 |
| 12 | MP0004087_abnormal_muscle_fiber | 3.32761677 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 3.11650144 |
| 14 | MP0004233_abnormal_muscle_weight | 2.99173681 |
| 15 | MP0005620_abnormal_muscle_contractility | 2.92856178 |
| 16 | MP0004130_abnormal_muscle_cell | 2.86778573 |
| 17 | MP0002332_abnormal_exercise_endurance | 2.36616865 |
| 18 | MP0000733_abnormal_muscle_development | 2.36207922 |
| 19 | MP0005645_abnormal_hypothalamus_physiol | 2.12778713 |
| 20 | MP0006036_abnormal_mitochondrial_physio | 2.10175091 |
| 21 | MP0005330_cardiomyopathy | 2.04515737 |
| 22 | MP0002108_abnormal_muscle_morphology | 1.91069764 |
| 23 | MP0002653_abnormal_ependyma_morphology | 1.76579971 |
| 24 | MP0004185_abnormal_adipocyte_glucose | 1.72600195 |
| 25 | MP0004084_abnormal_cardiac_muscle | 1.68308351 |
| 26 | MP0005167_abnormal_blood-brain_barrier | 1.67029205 |
| 27 | MP0003221_abnormal_cardiomyocyte_apopto | 1.49653300 |
| 28 | MP0003806_abnormal_nucleotide_metabolis | 1.43866259 |
| 29 | MP0005671_abnormal_response_to | 1.37363059 |
| 30 | MP0005266_abnormal_metabolism | 1.30860483 |
| 31 | MP0004215_abnormal_myocardial_fiber | 1.28617651 |
| 32 | MP0005666_abnormal_adipose_tissue | 1.26777563 |
| 33 | MP0003136_yellow_coat_color | 1.26555419 |
| 34 | MP0002971_abnormal_brown_adipose | 1.24953899 |
| 35 | MP0001986_abnormal_taste_sensitivity | 1.24147193 |
| 36 | MP0006035_abnormal_mitochondrial_morpho | 1.21798839 |
| 37 | MP0003763_abnormal_thymus_physiology | 1.20648436 |
| 38 | MP0010630_abnormal_cardiac_muscle | 1.16771332 |
| 39 | MP0004270_analgesia | 1.11948474 |
| 40 | MP0002972_abnormal_cardiac_muscle | 1.09387477 |
| 41 | MP0004484_altered_response_of | 1.06046267 |
| 42 | MP0003045_fibrosis | 1.05585783 |
| 43 | MP0004381_abnormal_hair_follicle | 0.98410070 |
| 44 | MP0003656_abnormal_erythrocyte_physiolo | 0.97067754 |
| 45 | MP0003137_abnormal_impulse_conducting | 0.95951271 |
| 46 | MP0005375_adipose_tissue_phenotype | 0.93883090 |
| 47 | MP0008872_abnormal_physiological_respon | 0.93741329 |
| 48 | MP0003705_abnormal_hypodermis_morpholog | 0.92982856 |
| 49 | MP0002102_abnormal_ear_morphology | 0.91829028 |
| 50 | MP0004043_abnormal_pH_regulation | 0.89720007 |
| 51 | MP0000013_abnormal_adipose_tissue | 0.89104293 |
| 52 | MP0004510_myositis | 0.88021686 |
| 53 | MP0000762_abnormal_tongue_morphology | 0.86045074 |
| 54 | MP0002876_abnormal_thyroid_physiology | 0.82132741 |
| 55 | MP0001873_stomach_inflammation | 0.79610167 |
| 56 | MP0005360_urolithiasis | 0.79289625 |
| 57 | MP0008789_abnormal_olfactory_epithelium | 0.79021259 |
| 58 | MP0001485_abnormal_pinna_reflex | 0.77230124 |
| 59 | MP0001544_abnormal_cardiovascular_syste | 0.77160044 |
| 60 | MP0005385_cardiovascular_system_phenoty | 0.77160044 |
| 61 | MP0008961_abnormal_basal_metabolism | 0.77057480 |
| 62 | MP0002127_abnormal_cardiovascular_syste | 0.75755920 |
| 63 | MP0002638_abnormal_pupillary_reflex | 0.74618534 |
| 64 | MP0009278_abnormal_bone_marrow | 0.72177860 |
| 65 | MP0000230_abnormal_systemic_arterial | 0.71535980 |
| 66 | MP0001529_abnormal_vocalization | 0.70960514 |
| 67 | MP0001984_abnormal_olfaction | 0.68650523 |
| 68 | MP0001968_abnormal_touch/_nociception | 0.68153881 |
| 69 | MP0005083_abnormal_biliary_tract | 0.67989292 |
| 70 | MP0005386_behavior/neurological_phenoty | 0.66370232 |
| 71 | MP0004924_abnormal_behavior | 0.66370232 |
| 72 | MP0004134_abnormal_chest_morphology | 0.66072932 |
| 73 | MP0002723_abnormal_immune_serum | 0.65241641 |
| 74 | MP0003950_abnormal_plasma_membrane | 0.65084263 |
| 75 | MP0002254_reproductive_system_inflammat | 0.64389470 |
| 76 | MP0001501_abnormal_sleep_pattern | 0.64023791 |
| 77 | MP0000685_abnormal_immune_system | 0.63913607 |
| 78 | MP0001800_abnormal_humoral_immune | 0.63457950 |
| 79 | MP0009250_abnormal_appendicular_skeleto | 0.62879547 |
| 80 | MP0002693_abnormal_pancreas_physiology | 0.62515640 |
| 81 | MP0005451_abnormal_body_composition | 0.61426899 |
| 82 | MP0002234_abnormal_pharynx_morphology | 0.61392201 |
| 83 | MP0009672_abnormal_birth_weight | 0.60422239 |
| 84 | MP0010329_abnormal_lipoprotein_level | 0.59433996 |
| 85 | MP0003693_abnormal_embryo_hatching | 0.59392791 |
| 86 | MP0002078_abnormal_glucose_homeostasis | 0.58142470 |
| 87 | MP0000266_abnormal_heart_morphology | 0.57955278 |
| 88 | MP0001661_extended_life_span | 0.57760876 |
| 89 | MP0005000_abnormal_immune_tolerance | 0.55670154 |
| 90 | MP0001765_abnormal_ion_homeostasis | 0.55618728 |
| 91 | MP0005551_abnormal_eye_electrophysiolog | 0.53754123 |
| 92 | MP0000003_abnormal_adipose_tissue | 0.53471496 |
| 93 | MP0000372_irregular_coat_pigmentation | 0.53295148 |
| 94 | MP0001835_abnormal_antigen_presentation | 0.53237589 |
| 95 | MP0000579_abnormal_nail_morphology | 0.51748412 |
| 96 | MP0001790_abnormal_immune_system | 0.50920774 |
| 97 | MP0005387_immune_system_phenotype | 0.50920774 |
| 98 | MP0004133_heterotaxia | 0.50119189 |
| 99 | MP0001819_abnormal_immune_cell | 0.49864342 |
| 100 | MP0001299_abnormal_eye_distance/ | 0.49839572 |
| 101 | MP0003011_delayed_dark_adaptation | 0.49755891 |
| 102 | MP0002114_abnormal_axial_skeleton | 0.49588421 |
| 103 | MP0002420_abnormal_adaptive_immunity | 0.49340967 |
| 104 | MP0005452_abnormal_adipose_tissue | 0.49206621 |
| 105 | MP0001849_ear_inflammation | 0.49036420 |
| 106 | MP0001664_abnormal_digestion | 0.47903682 |
| 107 | MP0005332_abnormal_amino_acid | 0.47314107 |
| 108 | MP0000689_abnormal_spleen_morphology | 0.47279993 |
| 109 | MP0003567_abnormal_fetal_cardiomyocyte | 0.47205491 |
| 110 | MP0004957_abnormal_blastocyst_morpholog | 0.45906020 |
| 111 | MP0006138_congestive_heart_failure | 0.45899932 |
| 112 | MP0008775_abnormal_heart_ventricle | 0.45649732 |
| 113 | MP0004147_increased_porphyrin_level | 0.45593511 |
| 114 | MP0005334_abnormal_fat_pad | 0.44257125 |
| 115 | MP0001730_embryonic_growth_arrest | 0.43174152 |
| 116 | MP0002796_impaired_skin_barrier | 0.42703103 |
| 117 | MP0005670_abnormal_white_adipose | 0.42150618 |
| 118 | MP0005319_abnormal_enzyme/_coenzyme | 0.41393245 |
| 119 | MP0004197_abnormal_fetal_growth/weight/ | 0.40750152 |
| 120 | MP0003828_pulmonary_edema | 0.37279837 |
| 121 | MP0003755_abnormal_palate_morphology | 0.34680071 |
| 122 | MP0008770_decreased_survivor_rate | 0.34444279 |
| 123 | MP0000383_abnormal_hair_follicle | 0.33855219 |
| 124 | MP0004142_abnormal_muscle_tone | 0.32931777 |
| 125 | MP0010030_abnormal_orbit_morphology | 0.32428587 |
| 126 | MP0008057_abnormal_DNA_replication | 0.31889870 |
| 127 | MP0003111_abnormal_nucleus_morphology | 0.30779530 |
| 128 | MP0000358_abnormal_cell_content/ | 0.30364497 |
| 129 | MP0005076_abnormal_cell_differentiation | 0.29268429 |
| 130 | MP0000678_abnormal_parathyroid_gland | 0.29108950 |
| 131 | MP0003984_embryonic_growth_retardation | 0.28666524 |
| 132 | MP0003941_abnormal_skin_development | 0.28345120 |
| 133 | MP0002089_abnormal_postnatal_growth/wei | 0.28054148 |
| 134 | MP0002088_abnormal_embryonic_growth/wei | 0.28021625 |
| 135 | MP0001672_abnormal_embryogenesis/_devel | 0.27950645 |
| 136 | MP0005380_embryogenesis_phenotype | 0.27950645 |
| 137 | MP0005376_homeostasis/metabolism_phenot | 0.27320025 |
| 138 | MP0003959_abnormal_lean_body | 0.26849046 |
| 139 | MP0010094_abnormal_chromosome_stability | 0.26694838 |
| 140 | MP0003123_paternal_imprinting | 0.26509032 |
| 141 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.26478526 |
| 142 | MP0009703_decreased_birth_body | 0.26013247 |
| 143 | MP0000343_altered_response_to | 0.25975313 |
| 144 | MP0002877_abnormal_melanocyte_morpholog | 0.24264183 |
| 145 | MP0002970_abnormal_white_adipose | 0.23962207 |
| 146 | MP0004085_abnormal_heartbeat | 0.23528341 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.52980874 |
| 2 | Nemaline bodies (HP:0003798) | 9.03967132 |
| 3 | Exercise-induced myalgia (HP:0003738) | 8.47609354 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 7.77959535 |
| 5 | Type 1 muscle fiber predominance (HP:0003803) | 7.12806545 |
| 6 | Distal arthrogryposis (HP:0005684) | 7.10396806 |
| 7 | Myopathic facies (HP:0002058) | 6.94402425 |
| 8 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.78319230 |
| 9 | Ulnar deviation of the wrist (HP:0003049) | 6.21832410 |
| 10 | Calf muscle hypertrophy (HP:0008981) | 5.97546045 |
| 11 | Round ear (HP:0100830) | 5.92237612 |
| 12 | Calcaneovalgus deformity (HP:0001848) | 5.47466814 |
| 13 | Difficulty running (HP:0009046) | 5.38273096 |
| 14 | Muscle fiber splitting (HP:0003555) | 5.10444869 |
| 15 | Deformed tarsal bones (HP:0008119) | 5.00701259 |
| 16 | Myoglobinuria (HP:0002913) | 4.95324433 |
| 17 | Absent phalangeal crease (HP:0006109) | 4.82789692 |
| 18 | Muscle stiffness (HP:0003552) | 4.67721153 |
| 19 | Hyporeflexia of lower limbs (HP:0002600) | 4.54330479 |
| 20 | EMG: myopathic abnormalities (HP:0003458) | 4.44087478 |
| 21 | Increased connective tissue (HP:0009025) | 4.29911377 |
| 22 | Rhabdomyolysis (HP:0003201) | 4.22133635 |
| 23 | Myotonia (HP:0002486) | 4.10130557 |
| 24 | Abnormal finger flexion creases (HP:0006143) | 4.00873801 |
| 25 | Abnormality of the calf musculature (HP:0001430) | 3.91943099 |
| 26 | Difficulty climbing stairs (HP:0003551) | 3.68944223 |
| 27 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.64061399 |
| 28 | Pelvic girdle muscle weakness (HP:0003749) | 3.59243237 |
| 29 | Shoulder girdle muscle weakness (HP:0003547) | 3.58312450 |
| 30 | Areflexia of lower limbs (HP:0002522) | 3.55028762 |
| 31 | Neck muscle weakness (HP:0000467) | 3.53799657 |
| 32 | Malignant hyperthermia (HP:0002047) | 3.53603860 |
| 33 | Rimmed vacuoles (HP:0003805) | 3.49407741 |
| 34 | Subaortic stenosis (HP:0001682) | 3.49306951 |
| 35 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.49306951 |
| 36 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.47234516 |
| 37 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.47234516 |
| 38 | Type II lissencephaly (HP:0007260) | 3.38935311 |
| 39 | Abnormality of the calcaneus (HP:0008364) | 3.34348584 |
| 40 | Increased variability in muscle fiber diameter (HP:0003557) | 3.20823408 |
| 41 | Progressive muscle weakness (HP:0003323) | 3.08699215 |
| 42 | Frequent falls (HP:0002359) | 2.95946371 |
| 43 | Cerebellar dysplasia (HP:0007033) | 2.94816096 |
| 44 | Heart block (HP:0012722) | 2.80616195 |
| 45 | Hyperkalemia (HP:0002153) | 2.75631133 |
| 46 | Anterior segment dysgenesis (HP:0007700) | 2.67072718 |
| 47 | EMG: neuropathic changes (HP:0003445) | 2.66590654 |
| 48 | Asymmetric septal hypertrophy (HP:0001670) | 2.64435359 |
| 49 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.62164218 |
| 50 | Dicarboxylic aciduria (HP:0003215) | 2.62164218 |
| 51 | Fatigable weakness (HP:0003473) | 2.58979932 |
| 52 | Abnormality of the neuromuscular junction (HP:0003398) | 2.58979932 |
| 53 | Distal lower limb muscle weakness (HP:0009053) | 2.55307421 |
| 54 | Paralysis (HP:0003470) | 2.52594143 |
| 55 | Abnormal atrioventricular conduction (HP:0005150) | 2.51020750 |
| 56 | Sudden death (HP:0001699) | 2.37407622 |
| 57 | Proximal amyotrophy (HP:0007126) | 2.32535158 |
| 58 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.31567510 |
| 59 | Slender build (HP:0001533) | 2.29091523 |
| 60 | Stridor (HP:0010307) | 2.27974531 |
| 61 | Limb-girdle muscle weakness (HP:0003325) | 2.27845036 |
| 62 | Muscular dystrophy (HP:0003560) | 2.25421528 |
| 63 | Increased muscle lipid content (HP:0009058) | 2.23580662 |
| 64 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.18209455 |
| 65 | Hypoplastic ischia (HP:0003175) | 2.15325699 |
| 66 | Left ventricular hypertrophy (HP:0001712) | 2.15038264 |
| 67 | Hepatic necrosis (HP:0002605) | 2.13159219 |
| 68 | Increased intramyocellular lipid droplets (HP:0012240) | 2.11815106 |
| 69 | Generalized muscle weakness (HP:0003324) | 2.09973177 |
| 70 | Fetal akinesia sequence (HP:0001989) | 2.08451269 |
| 71 | Bulbar palsy (HP:0001283) | 2.08161709 |
| 72 | Severe muscular hypotonia (HP:0006829) | 2.08013237 |
| 73 | Achilles tendon contracture (HP:0001771) | 2.07371569 |
| 74 | Abnormality of alanine metabolism (HP:0010916) | 2.04915609 |
| 75 | Hyperalaninemia (HP:0003348) | 2.04915609 |
| 76 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.04915609 |
| 77 | Metatarsus adductus (HP:0001840) | 2.04081192 |
| 78 | Gout (HP:0001997) | 2.02689633 |
| 79 | Gowers sign (HP:0003391) | 2.00436422 |
| 80 | Ulnar deviation of finger (HP:0009465) | 2.00115054 |
| 81 | Muscle fiber inclusion bodies (HP:0100299) | 10.0037997 |
| 82 | Facial diplegia (HP:0001349) | 1.97026406 |
| 83 | Limb-girdle muscle atrophy (HP:0003797) | 1.95725167 |
| 84 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.94580720 |
| 85 | Hepatocellular necrosis (HP:0001404) | 1.92915736 |
| 86 | Congenital stationary night blindness (HP:0007642) | 1.92636374 |
| 87 | Spinal rigidity (HP:0003306) | 1.91265277 |
| 88 | Weak cry (HP:0001612) | 1.91145083 |
| 89 | Lissencephaly (HP:0001339) | 1.90966792 |
| 90 | Scapular winging (HP:0003691) | 1.87394589 |
| 91 | Dilated cardiomyopathy (HP:0001644) | 1.86422078 |
| 92 | Abnormality of the ischium (HP:0003174) | 1.85907513 |
| 93 | Abnormality of the Achilles tendon (HP:0005109) | 1.85319612 |
| 94 | Nonprogressive disorder (HP:0003680) | 1.85002110 |
| 95 | Short palpebral fissure (HP:0012745) | 1.84802946 |
| 96 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.83016086 |
| 97 | Methylmalonic aciduria (HP:0012120) | 1.81947682 |
| 98 | Distal lower limb amyotrophy (HP:0008944) | 1.77829133 |
| 99 | Increased purine levels (HP:0004368) | 1.77791213 |
| 100 | Hyperuricemia (HP:0002149) | 1.77791213 |
| 101 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.77751080 |
| 102 | Cerebral palsy (HP:0100021) | 1.77681411 |
| 103 | Hyperglycinuria (HP:0003108) | 1.74846604 |
| 104 | Renal cortical cysts (HP:0000803) | 1.73833422 |
| 105 | Ketosis (HP:0001946) | 1.72646522 |
| 106 | Hip contracture (HP:0003273) | 1.70844756 |
| 107 | Waddling gait (HP:0002515) | 1.70825446 |
| 108 | Large for gestational age (HP:0001520) | 1.68432796 |
| 109 | Ragged-red muscle fibers (HP:0003200) | 1.67728189 |
| 110 | Genetic anticipation (HP:0003743) | 1.65056611 |
| 111 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.64344171 |
| 112 | Congenital hip dislocation (HP:0001374) | 1.63516403 |
| 113 | Testicular atrophy (HP:0000029) | 1.62957587 |
| 114 | Ventricular tachycardia (HP:0004756) | 1.62616743 |
| 115 | Easy fatigability (HP:0003388) | 1.59714431 |
| 116 | Mitochondrial inheritance (HP:0001427) | 1.59388966 |
| 117 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.59298055 |
| 118 | Bundle branch block (HP:0011710) | 1.56506057 |
| 119 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.53699101 |
| 120 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.52802281 |
| 121 | Type 2 muscle fiber atrophy (HP:0003554) | 1.51274432 |
| 122 | Ketoacidosis (HP:0001993) | 1.50662996 |
| 123 | Adducted thumb (HP:0001181) | 1.50456830 |
| 124 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.49380021 |
| 125 | Abnormality of lateral ventricle (HP:0030047) | 1.48893140 |
| 126 | Tarsal synostosis (HP:0008368) | 1.48728430 |
| 127 | Decreased circulating renin level (HP:0003351) | 1.48726199 |
| 128 | Methylmalonic acidemia (HP:0002912) | 1.48506243 |
| 129 | Lipoatrophy (HP:0100578) | 1.48397202 |
| 130 | Exercise intolerance (HP:0003546) | 1.47986136 |
| 131 | Cholelithiasis (HP:0001081) | 1.40623869 |
| 132 | Increased density of long bones (HP:0006392) | 1.40608654 |
| 133 | Oligomenorrhea (HP:0000876) | 1.39612081 |
| 134 | Muscle fiber atrophy (HP:0100295) | 1.39027453 |
| 135 | Abnormality of potassium homeostasis (HP:0011042) | 1.36660297 |
| 136 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.32470813 |
| 137 | Synostosis involving bones of the feet (HP:0009140) | 1.32470813 |
| 138 | Webbed neck (HP:0000465) | 1.29538978 |
| 139 | Long clavicles (HP:0000890) | 1.28235094 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 8.52096992 |
| 2 | TTN | 5.83928485 |
| 3 | PHKG1 | 5.22210945 |
| 4 | PHKG2 | 5.22210945 |
| 5 | NME1 | 4.52155741 |
| 6 | PIK3CG | 3.41204662 |
| 7 | NEK1 | 3.07228417 |
| 8 | TAOK3 | 2.93623607 |
| 9 | MAP2K3 | 2.64498905 |
| 10 | PINK1 | 2.41907553 |
| 11 | EPHA3 | 2.41345165 |
| 12 | PDK4 | 2.18660862 |
| 13 | PDK3 | 2.18660862 |
| 14 | BCKDK | 2.00239325 |
| 15 | MAP4K1 | 1.99651170 |
| 16 | TXK | 1.92893883 |
| 17 | MAP3K7 | 1.83912461 |
| 18 | SIK2 | 1.71981279 |
| 19 | MAP2K4 | 1.63956001 |
| 20 | MAPK12 | 1.57208819 |
| 21 | FRK | 1.55927132 |
| 22 | PDK2 | 1.55550219 |
| 23 | GRK6 | 1.53509408 |
| 24 | ADRBK2 | 1.52497342 |
| 25 | DAPK2 | 1.51866466 |
| 26 | TRIB3 | 1.48019606 |
| 27 | DMPK | 1.45307053 |
| 28 | TLK1 | 1.44643106 |
| 29 | WNK4 | 1.42419301 |
| 30 | TESK2 | 1.35543335 |
| 31 | MAP2K6 | 1.34890230 |
| 32 | TNK2 | 1.29054249 |
| 33 | MUSK | 1.23090938 |
| 34 | TBK1 | 1.22097799 |
| 35 | DYRK1B | 1.18365995 |
| 36 | PIK3CA | 1.09265248 |
| 37 | MAP3K3 | 1.07985385 |
| 38 | MAPKAPK3 | 1.05499475 |
| 39 | RIPK1 | 1.02256860 |
| 40 | KDR | 1.00122460 |
| 41 | KIT | 0.99335738 |
| 42 | CAMK4 | 0.97287449 |
| 43 | MAP4K2 | 0.94608993 |
| 44 | STK24 | 0.93184284 |
| 45 | MAP2K2 | 0.92215352 |
| 46 | PRKAA1 | 0.92178064 |
| 47 | IKBKE | 0.91340661 |
| 48 | MAPK13 | 0.89323844 |
| 49 | MAP3K13 | 0.88787224 |
| 50 | GRK1 | 0.86381713 |
| 51 | MARK1 | 0.81249192 |
| 52 | RPS6KA6 | 0.81197155 |
| 53 | TAOK1 | 0.80420867 |
| 54 | TAOK2 | 0.80017279 |
| 55 | MAP3K6 | 0.78281940 |
| 56 | SYK | 0.75062547 |
| 57 | AKT2 | 0.74458380 |
| 58 | MAPK11 | 0.73545501 |
| 59 | IKBKB | 0.73004482 |
| 60 | PRKAA2 | 0.71427228 |
| 61 | LATS2 | 0.70770174 |
| 62 | MAP3K11 | 0.69489082 |
| 63 | MAP3K14 | 0.69105759 |
| 64 | IRAK4 | 0.68100833 |
| 65 | PRKCQ | 0.67306348 |
| 66 | ITK | 0.67096084 |
| 67 | ZAK | 0.64026019 |
| 68 | SIK1 | 0.63405421 |
| 69 | RPS6KA5 | 0.63365430 |
| 70 | PNCK | 0.63244337 |
| 71 | WEE1 | 0.61333497 |
| 72 | RPS6KC1 | 0.61085334 |
| 73 | RPS6KL1 | 0.61085334 |
| 74 | MAP3K10 | 0.61022181 |
| 75 | EPHA2 | 0.58149239 |
| 76 | TTK | 0.57707146 |
| 77 | CCNB1 | 0.57242035 |
| 78 | CDC42BPA | 0.57230455 |
| 79 | EPHB1 | 0.53151737 |
| 80 | MAP2K1 | 0.52383075 |
| 81 | PRKCH | 0.52077121 |
| 82 | INSRR | 0.51889549 |
| 83 | TRPM7 | 0.51430977 |
| 84 | STK11 | 0.51076123 |
| 85 | CAMK1 | 0.50357479 |
| 86 | CHUK | 0.50167398 |
| 87 | DYRK3 | 0.49926105 |
| 88 | ZAP70 | 0.48434876 |
| 89 | PKN2 | 0.48366401 |
| 90 | BTK | 0.46892198 |
| 91 | NME2 | 0.46879324 |
| 92 | MARK3 | 0.46610383 |
| 93 | CAMK2G | 0.45507152 |
| 94 | PRKD3 | 0.45296346 |
| 95 | PKN1 | 0.44748060 |
| 96 | AKT3 | 0.44600028 |
| 97 | STK38L | 0.44190795 |
| 98 | LCK | 0.43972275 |
| 99 | BMPR1B | 0.43914877 |
| 100 | NEK9 | 0.43074893 |
| 101 | ADRBK1 | 0.42974662 |
| 102 | MAPK15 | 0.41129085 |
| 103 | ICK | 0.40498823 |
| 104 | EEF2K | 0.38530154 |
| 105 | OXSR1 | 0.36858010 |
| 106 | CAMK2A | 0.36819144 |
| 107 | PRKD2 | 0.36433634 |
| 108 | PTK2B | 0.36339898 |
| 109 | TIE1 | 0.35865879 |
| 110 | MARK2 | 0.35723222 |
| 111 | RPS6KA2 | 0.34359965 |
| 112 | TNIK | 0.33200960 |
| 113 | LATS1 | 0.32854819 |
| 114 | MAP3K5 | 0.32237016 |
| 115 | CAMKK1 | 0.31840539 |
| 116 | RPS6KB2 | 0.30871395 |
| 117 | HCK | 0.30335660 |
| 118 | PRKACB | 0.30295366 |
| 119 | CAMK2D | 0.30197402 |
| 120 | ERBB3 | 0.29070409 |
| 121 | CAMKK2 | 0.28545118 |
| 122 | GRK7 | 0.27336281 |
| 123 | TYK2 | 0.27031625 |
| 124 | MAPK3 | 0.26831179 |
| 125 | RPS6KA3 | 0.25428263 |
| 126 | STK3 | 0.25261479 |
| 127 | MAPK7 | 0.24474152 |
| 128 | BUB1 | 0.24450959 |
| 129 | NEK2 | 0.24214393 |
| 130 | ALK | 0.22914972 |
| 131 | MTOR | 0.20451766 |
| 132 | ILK | 0.20439759 |
| 133 | PLK1 | 0.19430548 |
| 134 | DDR2 | 0.19209026 |
| 135 | SGK1 | 0.18056196 |
| 136 | STK38 | 0.17505520 |
| 137 | MAPK10 | 0.16124241 |
| 138 | CDK4 | 0.15711040 |
| 139 | ERN1 | 0.14817719 |
| 140 | PRKACA | 0.14708690 |
| 141 | MAPK4 | 0.14590520 |
| 142 | BRSK2 | 0.14350649 |
| 143 | GSK3A | 0.13545552 |
| 144 | CDK8 | 0.13211269 |
| 145 | EIF2AK1 | 0.12772776 |
| 146 | AURKA | 0.12616785 |
| 147 | BMX | 0.12219389 |
| 148 | CDK12 | 0.12166624 |
| 149 | RPS6KA1 | 0.11913472 |
| 150 | MOS | 0.11905351 |
| 151 | GRK5 | 0.11672909 |
| 152 | LIMK1 | 0.11600447 |
| 153 | TYRO3 | 0.11262960 |
| 154 | PAK6 | 0.09902286 |
| 155 | CSNK1E | 0.09296370 |
| 156 | PRKG1 | 0.09294101 |
| 157 | MAP3K8 | 0.08679155 |
| 158 | PRKDC | 0.08141240 |
| 159 | KSR2 | 0.07203125 |
| 160 | CDK2 | 0.06533956 |
| 161 | PTK6 | 0.06328752 |
| 162 | RPS6KB1 | 0.06159775 |
| 163 | FLT3 | 0.05556412 |
| 164 | CHEK1 | 0.04299127 |
| 165 | CDK7 | 0.04287070 |
| 166 | TSSK6 | 0.03489870 |
| 167 | CHEK2 | 0.02877687 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.25956881 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.75819719 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.65536614 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.31414629 |
| 5 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.12238580 |
| 6 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.06763457 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.99935261 |
| 8 | Circadian rhythm_Homo sapiens_hsa04710 | 2.93102002 |
| 9 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.78823315 |
| 10 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.69495326 |
| 11 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.57303807 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.38609860 |
| 13 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.23882258 |
| 14 | Galactose metabolism_Homo sapiens_hsa00052 | 2.20933197 |
| 15 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.18796906 |
| 16 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.18103415 |
| 17 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.10313664 |
| 18 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.05000849 |
| 19 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.04579947 |
| 20 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.00065764 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.98259440 |
| 22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.95826733 |
| 23 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.95797115 |
| 24 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.85278408 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.78549008 |
| 26 | Insulin resistance_Homo sapiens_hsa04931 | 1.75828476 |
| 27 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.71373603 |
| 28 | Phototransduction_Homo sapiens_hsa04744 | 1.67384874 |
| 29 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.66170255 |
| 30 | Parkinsons disease_Homo sapiens_hsa05012 | 1.65941361 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.57510025 |
| 32 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.52221459 |
| 33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.43852810 |
| 34 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.43386962 |
| 35 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.42548857 |
| 36 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.38776672 |
| 37 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.38281364 |
| 38 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.35915434 |
| 39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.35401545 |
| 40 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.33896099 |
| 41 | Tight junction_Homo sapiens_hsa04530 | 1.33701008 |
| 42 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.27571059 |
| 43 | Alzheimers disease_Homo sapiens_hsa05010 | 1.27499240 |
| 44 | Peroxisome_Homo sapiens_hsa04146 | 1.27381445 |
| 45 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.27284987 |
| 46 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.25748102 |
| 47 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.22948273 |
| 48 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.22924453 |
| 49 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.21999458 |
| 50 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.21389128 |
| 51 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.20354378 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 1.18243901 |
| 53 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.14777775 |
| 54 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.09887569 |
| 55 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.09069985 |
| 56 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.06128988 |
| 57 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.05149534 |
| 58 | Viral myocarditis_Homo sapiens_hsa05416 | 1.03440756 |
| 59 | RNA transport_Homo sapiens_hsa03013 | 1.02830870 |
| 60 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.01478925 |
| 61 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.00492933 |
| 62 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.98045597 |
| 63 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.93265453 |
| 64 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.92603192 |
| 65 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91028758 |
| 66 | Huntingtons disease_Homo sapiens_hsa05016 | 0.88928122 |
| 67 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.88456327 |
| 68 | Salivary secretion_Homo sapiens_hsa04970 | 0.87948907 |
| 69 | RNA polymerase_Homo sapiens_hsa03020 | 0.87891041 |
| 70 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.86113185 |
| 71 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.85094874 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.84209562 |
| 73 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.83069410 |
| 74 | Proteasome_Homo sapiens_hsa03050 | 0.82202029 |
| 75 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.81798619 |
| 76 | Olfactory transduction_Homo sapiens_hsa04740 | 0.81444724 |
| 77 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.77331466 |
| 78 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.77129858 |
| 79 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.75900919 |
| 80 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.74335609 |
| 81 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.73331996 |
| 82 | Purine metabolism_Homo sapiens_hsa00230 | 0.71238210 |
| 83 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.70684863 |
| 84 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.69457702 |
| 85 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.69274903 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69177068 |
| 87 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.68056305 |
| 88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.64856734 |
| 89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64740797 |
| 90 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.63234953 |
| 91 | Allograft rejection_Homo sapiens_hsa05330 | 0.58665974 |
| 92 | RNA degradation_Homo sapiens_hsa03018 | 0.56930280 |
| 93 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.56273769 |
| 94 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.56201925 |
| 95 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.55084235 |
| 96 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52866291 |
| 97 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.52208822 |
| 98 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.51109903 |
| 99 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.51012918 |
| 100 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.50752622 |
| 101 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.50019356 |
| 102 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.49471938 |
| 103 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.49182886 |
| 104 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48853859 |
| 105 | Focal adhesion_Homo sapiens_hsa04510 | 0.48833391 |
| 106 | Lysine degradation_Homo sapiens_hsa00310 | 0.47777879 |
| 107 | Ribosome_Homo sapiens_hsa03010 | 0.46916936 |
| 108 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.46263934 |
| 109 | Circadian entrainment_Homo sapiens_hsa04713 | 0.44843378 |
| 110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44405105 |
| 111 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.43684278 |
| 112 | Taste transduction_Homo sapiens_hsa04742 | 0.42964327 |
| 113 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.42764419 |
| 114 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.42225669 |
| 115 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.40480699 |
| 116 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.38108475 |
| 117 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37330148 |
| 118 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35895078 |
| 119 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.35426434 |
| 120 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.34374792 |
| 121 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.33862722 |
| 122 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32861183 |
| 123 | Base excision repair_Homo sapiens_hsa03410 | 0.32443755 |
| 124 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32049791 |
| 125 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.31423757 |
| 126 | Platelet activation_Homo sapiens_hsa04611 | 0.31185661 |
| 127 | Morphine addiction_Homo sapiens_hsa05032 | 0.31013052 |
| 128 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27158230 |
| 129 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.27146115 |
| 130 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.26823438 |
| 131 | Insulin secretion_Homo sapiens_hsa04911 | 0.26267361 |
| 132 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.23268273 |
| 133 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.21330632 |
| 134 | Mismatch repair_Homo sapiens_hsa03430 | 0.19638261 |
| 135 | Adherens junction_Homo sapiens_hsa04520 | 0.19239179 |
| 136 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.15526395 |
| 137 | Cell cycle_Homo sapiens_hsa04110 | 0.14353358 |
| 138 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.12374101 |
| 139 | Thyroid cancer_Homo sapiens_hsa05216 | 0.10957701 |
| 140 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.10868012 |
| 141 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.10268130 |
| 142 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.10208709 |
| 143 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.09018537 |
| 144 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.07868525 |
| 145 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.06594454 |
| 146 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.06194271 |
| 147 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.03908284 |

